Alector Quote - ALEC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.8999

Bid

1.77

Offer

1.94

Volume

4,460,916

1.725 Day's Range 1.885

1.735 52 Week Range 8.90

Market Cap

186.062M

Previous Close

1.77

Open

1.78

Last Trade

500

1.8999

(formt)

Last Trade Time

Financial Volume

US$ 8,028,165

VWAP

1.7997

Average Volume (3m)

1,112,581

Shares Outstanding

97,932,605

Dividend Yield

PE Ratio

-1.40

Earnings Per Share (EPS)

-1.33

Revenue

97.06M

Net Profit

-130.39M

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.alector.com

Headquarters

Wilmington, Delaware, USA

Founded

Alector Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ALEC. The last closing price for Alector was US$1.77. Over the last year, Alector shares have traded in a share price range of US$ 1.735 to US$ 8.90.

Alector currently has 97,932,605 shares in issue. The market capitalisation of Alector is US$173.34 million. Alector has a price to earnings ratio (PE ratio) of -1.40.

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1601	-7.77184466019	2.06	2.06	1.735	1285287	1.87065593	CS
4	-1.9101	-50.1338582677	3.81	4.18	1.735	2119630	2.46839078	CS
12	-2.9601	-60.9074074074	4.86	6.14	1.735	1112581	3.32589646	CS
26	-2.3701	-55.5058548009	4.27	6.78	1.735	821087	4.07290469	CS
52	-6.4601	-77.273923445	8.36	8.9	1.735	734793	4.91213394	CS
156	-20.4401	-91.4955237243	22.34	24.005	1.735	652987	7.72060724	CS
260	-17.6801	-90.2967313585	19.58	45	1.735	704364	14.40057768	CS

ALEC - Frequently Asked Questions (FAQ)

What is the current Alector share price?

The current share price of Alector is US$ 1.8999

How many Alector shares are in issue?

Alector has 97,932,605 shares in issue

What is the market cap of Alector?

The market capitalisation of Alector is USD 173.34M

What is the 1 year trading range for Alector share price?

Alector has traded in the range of US$ 1.735 to US$ 8.90 during the past year

What is the PE ratio of Alector?

The price to earnings ratio of Alector is -1.4

What is the cash to sales ratio of Alector?

The cash to sales ratio of Alector is 1.88

What is the reporting currency for Alector?

Alector reports financial results in USD

What is the latest annual turnover for Alector?

The latest annual turnover of Alector is USD 97.06M

What is the latest annual profit for Alector?

The latest annual profit of Alector is USD -130.39M

What is the registered address of Alector?

The registered address for Alector is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Alector website address?

The website address for Alector is www.alector.com

Which industry sector does Alector operate in?

Alector operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M